Search Results - Dana-Farber Cancer Institute

Dana–Farber Cancer Institute

Dana–Farber Cancer Institute (DFCI) is a comprehensive cancer treatment and research center in Boston, Massachusetts. Dana-Farber is the founding member of the Dana-Farber/Harvard Cancer Center, Harvard's Comprehensive Cancer Center designated by the National Cancer Institute, and one of the 15 clinical affiliates and research institutes of Harvard Medical School.

As of 2023, Dana-Farber is ranked the #4 cancer hospital in the world. Two Nobel laureates in Physiology or Medicine are among its past and present faculty.

In 2024, an investigation revealed evidence of research misconduct in dozens of studies authored by Dana-Farber researchers, including then President and CEO Laurie Glimcher, the Executive Vice President and COO, and the Research Integrity Officer. In response to these findings, Dana-Farber retracted 7 papers and corrected 31 others. In October 2024, Laurie Glimcher stepped down as President and CEO. Provided by Wikipedia
  • Showing 1 - 2 results of 2
Refine Results
  1. 1

    Breast Cancer

    Published 2008
    “…Dana-Farber Cancer Institute…”
    Click Here to View Status and Holdings.
    Unknown
  2. 2

    Atlas of diagnostic oncology

    Published 2010
    “…Dana-Farber Cancer Institute…”
    Click Here to View Status and Holdings.
    Book